We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tian An Pharmaceutical Co Ltd (PK) | USOTC:TNPH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0066 | 0.0012 | 0.014 | 0.00 | 21:02:15 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 21, 2008
Nevada None None --------------------------------------------------------------------------- (State or other jurisdiction (Commission File No.) (IRS Employer (State or other jurisdiction (Commission File No.) (IRS Employer |
of incorporation) Identification No.) Level 11, International Trade Centre, No. 196 Xiaozhai East Road Xi'an, China ---------------------------------------------------------- (Address of principal executive offices, including Zip Code) |
Registrant's telephone number, including area code: 0086-29-85381586
Item 4.01 Change in Registrant's Certifying Accountant
Effective February 21, 2008 Wen Jiang & Company resigned as the Company's independent certified public accountants. Wen Jiang & Company were retained on February 14, 2008 and did not audit the Company's financial statements. During the Company's two most recent fiscal years and subsequent interim period ended February 21, 2008 there were no disagreements with Wen Jiang & Company on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Wen Jiang & Company, would have caused them to make reference to such disagreements in any report they may have issued on the Company's financial statements.
Effective February 29, 2008 the Company hired Kabani & Company, Inc. as the Company's independent registered public accounting firm.
Kabani & Company did not provide the Company with advice regarding the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, that was an important factor considered by the Company in reaching a decision as to an accounting, auditing or financial reporting issue. During the two most recent fiscal years and subsequent interim period ended February 29, 2008, the Company did not consult with Kabani & Company regarding any matter that was the subject of a disagreement or a reportable event as defined in the regulations of the Securities and Exchange Commission.
The decision to hire Kabani & Company as the Company's independent registered public accountants was recommended and approved by the directors of the Company. The Company does not have an audit committee.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
16. Letter from the Company's former independent registered public accountants.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 28, 2008 TIAN'AN PHARMACEUTICAL CO., LTD. By: /s/ Weng Jianjun ---------------------------------------- Weng Jianjun, Principal Executive Officer |
1 Year Tian An Pharmaceutical (PK) Chart |
1 Month Tian An Pharmaceutical (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions